Atlas Trials

Pharmacokinetic Study of Thalidomide in Subjects With Multiple Myeloma

Clinical trial NCT01937442 · COMPLETED

Trial details

NCT number
NCT01937442
Sponsor
Celgene
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2013-11-07
Primary completion
2015-09-23
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.